1. Innovative sapphire dosing pumps for highly-accurate
filling of liquid pharmaceuticals.
Such dosing pumps are being used in pharmaceutical,
chemical, food, perfume and other industries.
The Product is high-yielding and cost-effective.
About Product
PharmaSapphire

2.  dosing pumps are highly resistant to wear and tear
 increased chemical purity of liquid pharmaceuticals being dosed
 increased efficiency of human medical products
 2-3 times increased shelf life of pharmaceutical products
 10 years of manufacturer warranty for the Product (1 year at the market)
 generally, the profit is 1000% per product unit
 payback period: 15 months
 broad distribution area
 ecologically friendly production
Product uniqueness
and competitive
advantages
Investment
advantages
Product Uniqueness
PharmaSapphire

3. Other world markets – 38%
Key Competitors’ Market
Major Distribution Area
RUSSIA
30% of total world
production of
pharmaceuticals
25% 7%
PharmaSapphire

4. Project Team
Vitali Savenkov – project
initiator, patent holder.
Experienced in managing
industrial processes and
supervising more than
100 employees.
The project scientific staff is represented by five Doctors of
Biological Sciences, Pharmacy, Chemistry , Physical and
Mathematical Sciences. They all are professors, some of them
are of world-wide reputation. They are known for their
numerous scientific achievements and as the authors of many
well-known scientific works and patents. They received a lot
of national awards for their scientific and technical
breakthroughs. The Company’s Sales Director has a long
experience and knows techniques on how to sell
manufacturing equipment. He was engaged in and knows
how to create a dealership network from zero cycle.
The Project Design Manager was one of the originators who
were preparing design-engineering documentation for
sapphire dosing pumps. Currently, the Company has
preliminary orders for 1,000 sapphire dosing pumps from
large Russian pharmaceutical companies, which is around 7
million US dollars.
PharmaSapphire
The Company holds two Russian patents, there were filed new applications for Russian and
international patents.

5. Project Needs
The Project needs investments of $5.5 mln. USD
PharmaSapphire
Investment Expenditures Pie Chart
Equipment $2.5
mln. USD
R&D $1 mln.
USD
Marketing $0.8
mln. USD
Other $1.2 mln.
USD

6. Thank you for your attention!
PharmaSapphire
Vitali Savenkov,
General Director,
+7 (909) 676-5128,
sapf@inbox.ru
www.sapptech.ru
Skolkovo Investment Office
Eduard Kanalosh
+7 (495) 967-0148,
ekanalosh@sk.ru
www.sk.ru

7. Thank you for your attention!
PharmaSapphire
Vitali Savenkov,
General Director,
+7 (909) 676-5128,
sapf@inbox.ru
www.sapptech.ru
Skolkovo Investment Office
Eduard Kanalosh
+7 (495) 967-0148,
ekanalosh@sk.ru
www.sk.ru